Health Catalyst, Inc. — Director's Dealing 2021

Apr 9, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-03-29

Reporting Person: Hinton Bryan Richard (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	31250.00	Direct
Common Stock	25000.00	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$10.80	2028-09-27	Common Stock (4940.00)		Direct
Stock Options (Right to buy)	$10.78	2028-05-03	Common Stock (1480.00)		Direct

Footnotes

F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on September 1, 2020 and the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

F2: Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2021 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.

F3: Subject to the terms of the 2019 Plan, 25% of the shares vested on September 25, 2019, and the remaining 75% vested or will vest in 36 equal monthly installments thereafter.

F4: Subject to the terms of the 2019 Plan, 25% of the shares vested on May 3, 2019, and the remaining 75% vested or will vest in 36 equal monthly installments thereafter.